DK448988D0 - Praeparat af et alfa-amideringsenzym og fremgangsmaade til fremstilling og anvendelse deraf - Google Patents

Praeparat af et alfa-amideringsenzym og fremgangsmaade til fremstilling og anvendelse deraf

Info

Publication number
DK448988D0
DK448988D0 DK448988A DK448988A DK448988D0 DK 448988 D0 DK448988 D0 DK 448988D0 DK 448988 A DK448988 A DK 448988A DK 448988 A DK448988 A DK 448988A DK 448988 D0 DK448988 D0 DK 448988D0
Authority
DK
Denmark
Prior art keywords
dna sequence
enzyme
amidization
alfa
preparing
Prior art date
Application number
DK448988A
Other languages
English (en)
Other versions
DK448988A (da
DK175538B1 (da
Inventor
James P Gilligan
Barry N Jones
Nozer M Mehta
Arthur H Bertelsen
Original Assignee
Unigene Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22196693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK448988(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unigene Lab Inc filed Critical Unigene Lab Inc
Publication of DK448988D0 publication Critical patent/DK448988D0/da
Publication of DK448988A publication Critical patent/DK448988A/da
Application granted granted Critical
Publication of DK175538B1 publication Critical patent/DK175538B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
DK198804489A 1987-08-14 1988-08-11 Fremgangsmåde til fremstilling af et alfa-amiderende enzym, genmanipuleret mikroorganisme eller værtscelle og rekombinant DNA-molekyle,............. DK175538B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/086,161 US6319685B1 (en) 1984-09-27 1987-08-14 Alpha-amidating enzyme compositions and processes for their production and use
US8616187 1987-08-14

Publications (3)

Publication Number Publication Date
DK448988D0 true DK448988D0 (da) 1988-08-11
DK448988A DK448988A (da) 1989-02-15
DK175538B1 DK175538B1 (da) 2004-11-29

Family

ID=22196693

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804489A DK175538B1 (da) 1987-08-14 1988-08-11 Fremgangsmåde til fremstilling af et alfa-amiderende enzym, genmanipuleret mikroorganisme eller værtscelle og rekombinant DNA-molekyle,.............

Country Status (13)

Country Link
US (1) US6319685B1 (da)
EP (2) EP0308067A3 (da)
JP (1) JP2979172B2 (da)
KR (1) KR0136611B1 (da)
AT (1) ATE198355T1 (da)
CA (1) CA1341454C (da)
DE (1) DE3856446T2 (da)
DK (1) DK175538B1 (da)
FI (1) FI883722A (da)
HU (3) HU213227B (da)
LT (1) LT4029B (da)
NO (1) NO883592L (da)
RU (2) RU2080385C1 (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319685B1 (en) 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
US4708934A (en) * 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
US5789234A (en) * 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US5871995A (en) * 1989-08-15 1999-02-16 Shiseido Company, Ltd. Purified enzymes participating in C-terminal amidation
DE69114583T2 (de) * 1990-06-01 1996-06-13 Japat Ltd Peptdidylhydroxylglycine N-C Lyase und DNS dafür kodierend.
US5580751A (en) * 1990-09-14 1996-12-03 Carlsberg A/S Process for the preparation of C-terminally amidated peptides
DK67691D0 (da) * 1991-03-01 1991-04-15 Carlbiotech Ltd As Enzymatisk fremgangsmaade til c-terminal modificering af peptider og mellemprodukter til brug ved fremgangsmaaden
WO1996017941A2 (en) * 1994-12-07 1996-06-13 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
EP2088188B1 (en) 1997-04-16 2011-08-31 Unigene Laboratories, Inc. Direct expression of peptides into culture media
JP4483579B2 (ja) 2002-07-26 2010-06-16 味の素株式会社 トリペプチド以上のペプチドの製造方法
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US7648965B2 (en) 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7531518B2 (en) 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060089723A1 (en) * 2004-10-25 2006-04-27 Murphy Kieran P Method for bone augmentation
US7445911B2 (en) 2004-11-24 2008-11-04 Unigene Laboratories Inc. Enzymatic reactions in the presence of keto acids
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US20060293667A1 (en) * 2005-05-19 2006-12-28 Agnes Vignery Bone implant device and methods of using same
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
AU2010206614B2 (en) 2009-01-22 2015-03-26 Keybioscience Ag Treatment for obesity
US20140066370A1 (en) 2009-11-23 2014-03-06 Amylin Pharmaceuticals, Llc Polypeptide Conjugate
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
WO2012050923A2 (en) 2010-09-28 2012-04-19 Amylin Pharmaceuticals, Inc. Engineered polypeptides having enhanced duration of action
EP3241558B1 (en) 2010-09-28 2021-03-03 Aegerion Pharmaceuticals, Inc. Highly soluble leptins
HUE042929T2 (hu) 2011-06-15 2019-07-29 Resother Pharma Aps Gyulladáscsökkentõ gyógyszerészeti termékek
EP2729160B1 (en) 2011-07-08 2019-03-27 Aegerion Pharmaceuticals, Inc. Engineered polypeptides having enhanced duration of action and reduced immunogenicity
EP2729481B1 (en) 2011-07-08 2018-10-17 Amylin Pharmaceuticals, LLC Engineered polypeptides having enhanced duration of action with reduced immunogenicity
JP6170933B2 (ja) 2011-11-02 2017-07-26 キーバイオサイエンス・アクチエンゲゼルシャフト ペプチドの使用
ES2673617T3 (es) 2011-11-02 2018-06-25 Keybioscience Ag Miméticos de calcitonina para tratar enfermedades y trastornos
US9533022B2 (en) 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
HUE037663T2 (hu) 2013-11-14 2018-09-28 Keybioscience Ag Kalcitonin mimetikumok betegségek és rendellenességek kezelésére
WO2015084875A1 (en) 2013-12-02 2015-06-11 Stealth Peptides International, Inc. Compositions and methods for treating vitiligo
EP3148565A4 (en) 2014-05-28 2018-06-06 Stealth Biotherapeutics Corp Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
CA2950410A1 (en) 2014-05-28 2015-12-03 D. Travis Wilson Therapeutic compositions including therapeutic small molecules and uses thereof
US10627392B2 (en) 2014-06-17 2020-04-21 Stealth Biotherapeutics Corp Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening
GB201500263D0 (en) 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders
CA2973099C (en) 2015-01-12 2021-09-14 Enteris Biopharma, Inc. Solid oral dosage forms
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
GB202001024D0 (en) 2020-01-24 2020-03-11 Key Bioscience Ag Oxyntomodulin mimetics
WO2022266467A2 (en) 2021-06-17 2022-12-22 Dana-Farber Cancer Institute, Inc. Recombinant histone polypeptide and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US655366A (en) 1900-05-16 1900-08-07 Simeon C Lawlor Window-cleaner.
US4518693A (en) * 1982-11-01 1985-05-21 Research Corporation Immobilized biocatalysts
EP0134631B1 (en) 1983-06-15 1991-04-03 Celltech Limited Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents
GB2141430B (en) 1983-06-15 1987-01-21 Kingdon Craig R Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents
US4549986A (en) 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP
US6319685B1 (en) 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
US4708934A (en) * 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
JPS6229997A (ja) 1985-04-08 1987-02-07 Sankyo Co Ltd Ｃ末端にプロリンアミドを有するペプチドの製法
GB8523156D0 (en) 1985-09-19 1985-10-23 Celltech Ltd Polypeptide production
JPS62177184A (ja) 1986-01-29 1987-08-04 Toyota Motor Corp 鋳鉄製内燃機関用シリンダヘツドおよびその製造方法
JPH0775541B2 (ja) 1986-06-07 1995-08-16 壽之 松尾 Ｃ末端アミド化酵素及びその製造方法
EP0249477A3 (en) 1986-06-12 1988-01-20 Immunex Corporation Functional recombinant analog polypeptides devoid of hydrophobic amino acids
JP2598050B2 (ja) 1987-07-17 1997-04-09 サントリー株式会社 Ｃ−末端α−アミド化酵素
US6255067B1 (en) 1987-09-15 2001-07-03 The Johns Hopkins University cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM)
JP2845468B2 (ja) 1989-01-17 1999-01-13 サントリー株式会社 ヒト甲状腺由来Ｃ―末端α―アミド化酵素

Also Published As

Publication number Publication date
FI883722A (fi) 1989-02-15
ATE198355T1 (de) 2001-01-15
RU2080385C1 (ru) 1997-05-27
EP0308067A2 (en) 1989-03-22
NO883592L (no) 1989-02-15
JP2979172B2 (ja) 1999-11-15
EP0529742A1 (en) 1993-03-03
KR0136611B1 (ko) 1998-04-25
US6319685B1 (en) 2001-11-20
NO883592D0 (no) 1988-08-12
HU213227B (en) 1997-07-28
CA1341454C (en) 2004-04-20
DE3856446D1 (de) 2001-02-01
AU2057688A (en) 1989-02-16
AU629795B2 (en) 1992-10-15
DK448988A (da) 1989-02-15
RU2252961C2 (ru) 2005-05-27
HU212071A9 (en) 1996-02-28
DE3856446T2 (de) 2001-07-12
EP0308067A3 (en) 1989-07-26
EP0529742B1 (en) 2000-12-27
LTIP1656A (en) 1995-07-25
KR890003947A (ko) 1989-04-19
JPH02104281A (ja) 1990-04-17
LT4029B (en) 1996-08-26
DK175538B1 (da) 2004-11-29
HU00552A9 (en) 1995-10-30
FI883722A0 (fi) 1988-08-10

Similar Documents

Publication Publication Date Title
DK448988A (da) Praeparat af et alfa-amideringsenzym og fremgangsmaade til fremstilling og anvendelse deraf
DK0691405T3 (da) Materialer og fremgangsmåde til hypersecernering af aminosyrer
ATE143690T1 (de) Cd40 kodierende dna
ATE132902T1 (de) Humane mangan-superoxiddismutase (hmn-sod)
DK219087D0 (da) Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri
DK0843961T3 (da) Kimærisk mus og fremgangsmåde til at producere samme
DK234088D0 (da) Fremgangsmaade til fremstilling af kimere plantegener og genetisk transformerede mikroorganismer eller cellelinier
EP0732397A3 (en) Modified hepatocytes and uses therefor
DK160998C (da) Plasmid indeholdende dna fra en plasmidfraktion af b.thuringiensis, e.coli bakteriestamme indeholdende plasmidet, gensplejset e.coli bakteriestamme, fremgangsmaade til fremstilling af plasmidet, fremgangsmaade til at skabe en gensplejset e.coli bakteriestamme, fremgangsmaade til fremstilling af bacillus thuringiensis krystalprotein og fremgangsmaade til at opnaa insekticid virkning i et miljoe
GB8718779D0 (en) Dna sequence & expression vector
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DK0516647T3 (da) Polypeptider, som er involveret i biosyntesen af cobalaminer og/eller cobamider, DNA-sekvenser, som koder for disse polypep
DK203588A (da) Fremgangsmaade til fremstilling af proteiner
EP2281892A3 (en) Methods for producing polypeptides in respiratory-deficient Trichoderma cells
ES554327A0 (es) Un procedimiento para preparar un plasmido recombinante
DE50109097D1 (de) Promotoren zur genexpression in karyopsen von pflanzen
DE69015843T2 (de) Cytochrom-C-Gen aus einer Wasserstoffbakterie.
ATE122097T1 (de) Expressionsvektor und verfahren zur regulierbaren herstellung von proteinen in eukaryonten.

Legal Events

Date Code Title Description
PUP Patent expired